TRIVAROP

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
>
No longer registered as of 13 May 2022 - Registration as it was on 01 Dec 2020
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

17,500€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    TRIVAROP   (TRIVAROP)

    EU Transparency Register

    78758165752-12 First registered on 28 Apr 2011

    Goals / Remit

    Joris Vandeputte is specialised in biotechnology and vaccines particularly those fields related with innovation, international relations, development and Sustainable Development Goals, sanitary prevention,vaccination,zoonoses, one health policies, poverty related diseases such as Malaria, Tuberculosis, and humanitarian aid.


    Joris Vandeputte particularly focuses on EU Innovation Union, HORIZON EUROPE and beyond, innovative solutions in Health, biotechnology with positive impact on added value creation.

    Main EU files targeted

    - REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
    of 9 March 2016: interaction with Commission and parliament on Rabies in the EU and neighboring countries
    - HORIZON EUROPE: investment in poverty related diseases, interaction with Development Committee

    Address

    Head Office
    de la Tannerie, 14
    COLFONTAINE 7340
    BELGIUM
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 14 May 2024

    Name Start date End Date
    Mr Joris VANDEPUTTE 17 Nov 2020 17 Nov 2021
    Mr Joris VANDEPUTTE 13 Nov 2019 13 Nov 2020
    Mr Joris VANDEPUTTE 15 Nov 2018 13 Nov 2019
    Mr Joris VANDEPUTTE 28 Nov 2017 14 Nov 2018
    Mr Joris VANDEPUTTE 15 Nov 2016 12 Nov 2017
    Mr Joris VANDEPUTTE 17 Nov 2015 12 Nov 2016
    Mr Joris VANDEPUTTE 11 Nov 2014 10 Nov 2015
    Mr Joris VANDEPUTTE 08 Nov 2013 07 Nov 2014
    Mr Joris VANDEPUTTE 22 Nov 2012 08 Nov 2013
    Mr Joris VANDEPUTTE 18 Jan 2012 08 Feb 2013

    Complementary Information

    The part of time in direct relation with the Transparency register at the European Parliament is estimated at around 25% of the total activity, mainly IMI Project Zoonosis Anticipation Initiative (ZAPI) and Rabies control on behalf of IABS, Malaria Fund and activities related to ACP livestock disease control, control of COVID-19, Europe's sovereignty in vaccine development and production

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Self-employed consultants

  • Networking

    Affiliation

    European TB coalition
    Parliamentary working group on Innovation, Access to Medicines and Poverty-Related Diseases
    IABS (International Alliance for Biological Standardisation), IABS-EU the European Affiliate of IABS
    the African Forum in Brussels
    Civil society on poverty related diseases

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    17,500€

    EU grant income for closed financial year

    30,000 € (Source: IMI (Innovative Medecines Initiative))

    Other financial info

    Total turnover for all clients, activities related with transparency register (around € 20 000) and activities not related with transparency register (€ 170000)

    Declared lobby clients

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    - Strengthening animal health services in ACP countries, early warning for zoonotic and pandemic diseases
    - Strengthening Europe's sovereignty for vaccine development and productionIMI program ZAPI (Zoonosis anticipation preparedness initiative) and REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on veterinary medicinal products and repealing Directive 2001/82/EC: interaction with. ENVI and EMA on innovation and platform technologies for vaccine and antibody development and production in case of pandemic emergencies
    - EU 2020, competitive Europe with ENVI committee drafting arguments for investment in EU sovereignty in vaccine development and production in the COVID urgency
    - Europe and poverty related diseases: EU malaria Fund presentation to DEV committee

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard